Skip to main content
SpringerLink
Log in

Breast Cancer Screening

  • Chapter
  • First Online:
Breast Cancer Management for Surgeons

Abstract

Mammographic screening programmes aiming to reduce breast cancer mortality through early detection and treatment have been established in many European countries. Meta-analysis of screening trials and analysis of observational studies show a significant mortality reduction from mammographic screening. This needs to be balanced against the potential harms of mammographic screening, in particular over diagnosis. Although it remains a controversial subject, the current majority opinion is that the benefits in terms of mortality reduction outweigh any potential harms. Women should be given information regarding the potential risks and benefits to be able to make a fully informed choice to attend for breast screening.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Wilson JMG, G. Jungner. Principles and practices of screening for disease. Geneva: World Health Organization; 1968. Report No: Public Health Papers. 1968; No. 34.

    Google Scholar 

  2. Perry N, Broeders M, de Wolf C et al. European guidelines for the quality assurance in breast cancer screening and diagnosis. European guidelines. Luxembourg: office for official publications of the european communities, 4th ed. 2006. p. 416.

    Google Scholar 

  3. Ferlay J, Soerjomataram I, Ervik M, et al. Estimated cancer incidence, mortality, and prevalence worldwide in 2012. Lyon: IARC Press; 2014. p. 10.

    Google Scholar 

  4. Nielsen M, Jensen J, Andersen J. Precancerous and cancerous breast lesions during lifetime and at autopsy. A study of 83 women. Cancer. 1984;54(4):612–5.

    Article  CAS  PubMed  Google Scholar 

  5. Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer. 1995;76(7):1197–200.

    Article  CAS  PubMed  Google Scholar 

  6. Eusebi V, Feudale E, Foschini MP, et al. Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol. 1994;11(3):223–35.

    CAS  PubMed  Google Scholar 

  7. Group EBCC, Group ER, Bijker N, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 2006;24(21):3381–7. doi:10.1200/JCO.2006.06. [pii] 10.1200/JCO.2006.06.1366 [doi][published Online First: Epub Date]|

    Article  Google Scholar 

  8. Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and bowel project experience. Semin Oncol. 2001;28(4):400–18.

    Article  CAS  PubMed  Google Scholar 

  9. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 1999;340(19):1455–61.

    Article  CAS  PubMed  Google Scholar 

  10. Holmberg LEA, Zack M. Do screen-detected invasive breast cancers have a natural history of their own? Eur J Cancer. 1992;28A:920–3.

    Article  CAS  PubMed  Google Scholar 

  11. Giordano L, von Karsa L, Tomatis M, Majek O, de Wolf C, Lancucki L, et al. Mammographic screening programmes in Europe: organization, coverage and participation. J Med Screen. 2012;19:72–82.

    Article  PubMed  Google Scholar 

  12. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, European Commission. European guidelines for quality assurance in breast cancer screening and diagnosis. 4th ed. Luxembourg: Office for Official Publications of the European Communities; 2006.

    Google Scholar 

  13. Breast Screening Programme, England: 2014–15. Health and Social Care Information Centre 2016.

    Google Scholar 

  14. Altobelli E, Lattanzi A. Breast cancer in European Union: an update of screening programmes as of march 2014 (review). Int J Oncol. 2014;45:1785–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Justin Shows DW. Inferences for the lead time in breast cancer screening trials under a stable disease model. Cancers (Basel). 2011;3(2):2131–40.

    Article  Google Scholar 

  16. Group BSFT. The frequency of breast cancer screening: results from the UKCCCR randomised trial. United Kingdom co-ordinating committee on cancer research. Eur J Cancer. 2002;38(11):1458–64.

    Article  Google Scholar 

  17. Berrington de González A. Estimates of the potential risk of radiation-related cancer from screening in the UK. J Med Screen. 2011;18(4):163–4.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Whelan P, Evans A, Wells M, et al. The effect of mammography pain on repeat participation in breast cancer screening: a systematic review. Breast. 2013;22(4):389–94. 2013;22(4):389-94

    Article  Google Scholar 

  19. Bond M, Pavey T, Welch K, et al. Systematic review of the psychological consequences of false-positive screening mammograms. Health Technol Assess. 2013;17:1–170.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Pharoah PDP, Sewell B, Fitzsimmons D, et al. Cost effectiveness of the NHS breast screening programme: life table model. BMJ. 2013;346:f2618. BMJ 2013; 346: f2618

    Article  PubMed  PubMed Central  Google Scholar 

  21. Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, McDonald C, Muir BB, Prescott RJ, Shepherd SM. The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer. 1994;70(3):542–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ. 1992;147(10):1459–76.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Anthony M, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50–59 years. Journal of National Cancer Institute. 2000;92(18):1490–9.

    Article  Google Scholar 

  24. Semiglazov V, Alexey M, Moiseenko VM, et al. Results of a prospective randomized investigation [Russia (St.Petersburg) / WHO] to evaluate the significance of self-examination for the early detection of breast cancer. Vopr Onkol. 2003;49(4):434–41. 2003;49(4):434-41

    CAS  PubMed  Google Scholar 

  25. Thomas DB, Gao DL, Ray RM, et al. Randomized trial of breast self-examination in shanghai: final results. J Natl Cancer Inst. 2002;94(19):1445–57.

    Article  PubMed  Google Scholar 

  26. Marmot MG, Douglas A, Cameron D, et al. The benifits and harms of breast cancer screening: an independent review. BJC. 2012;108:2205–40.

    Article  Google Scholar 

  27. Warren RML, Duffy SW, Olsen AH, et al. The value of the second view in screening mammography. Br J Radiol. 1996;69:105–8.

    Article  CAS  PubMed  Google Scholar 

  28. Skaane P, Hofvind S, Skjennald A, et al. Randomized trial of screen-film versus full-field digital mammography with soft-copy reading in population-based screening program: follow-up and final results of Oslo II study. Radiology. 2007;244(3):708–17.

    Article  PubMed  Google Scholar 

  29. Ciatto S, Houssami N, Bernardi D, et al. Integration of 3D digital mammography with tomosynthesis for population breastcancer screening (STORM): a prospective comparison study. Lancet Oncol. 2013;14:583–9.

    Article  PubMed  Google Scholar 

  30. Ohuchi N, Suzuki A, Sobue T, et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan strategic anti-cancer randomized trial (JSTART): a randomised controlled trial. Lancet. 2016;387:341–8.

    Article  PubMed  Google Scholar 

  31. Phi XA, Houssami N, Obdeijn IM, et al. Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis. J Clin Oncol. 2015;33:349–56.

    Article  PubMed  Google Scholar 

  32. Sam S. Periodic screening for breast cancer: the HIP randomized controlled trial. Health Insurance Plan. J Natl Cancer Inst Monogr. 1997;22:27–30.

    Google Scholar 

  33. Tabar L, Duffy SW, Yen MF, et al. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point. J Med Screen. 2002;9(4):159–62.

    Article  CAS  PubMed  Google Scholar 

  34. Olsen O, Gøtzsche PC. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2001;4:CD001877.

    Google Scholar 

  35. Lauby-Secrtan B, Scoccianti C. Dana Loomis et al. breast-cancer screening- viewpoint of the IARC working group. N Engl J Med. 2015;372(24):2353–8.

    Article  Google Scholar 

  36. Oeffinger KC, Fontham ET, Etzioni R, et al. Breast cancer screening for women at average risk: 201 guideline update from the American Cancer Society. JAMA. 2015;314(15):1599–614.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Surveillance, Epidemiology ans End Results (SEER. Programme Cancer Statistics Review (1973–1995). Bethesda, MD, national Cancer Institute, Division of Cancer prevention and Control, Surveillance Programme, Cancer statistics branch 1998 UPDATED REF.

    Google Scholar 

  38. Gupta SKD-JA, Fenn N, Morgan JM, Mansel RE. The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ). Cancer. 1997;80(9):1940–745.

    Article  Google Scholar 

  39. Moulis S, Sgroi D. Re-evaluating early breast neoplasia. Breast Cancer Res Treat. 2008;10(1):302.

    Article  Google Scholar 

  40. Vos CB, ter Haar NT, Rosenberg C, Peterse JL, Cleton-Jansen AM, Cornelisse CJ, et al. Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type. Br J Cancer. 1999;81(8):1410–8. 1999;81(8):1410-18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Ellis IO. Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biology. Mod Pathol. 2010;23(2):S1–7.

    Article  CAS  PubMed  Google Scholar 

  42. van Luijt PAHE, Fracheboud J, Overbeek LI, Broeders MJ, Wesseling J, den Heeten GJ, de Koning HJ. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis inbreast cancer screening. Breast Cancer Res. 2016;18(1):47.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Elshof LE, Tryfonidis K, Slaets L, van Leeuwen-Stok AE, Skinner VP, Dif N, et al. Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - the LORD study. Eur J Cancer. 2015;51(12):1497–510.

    Article  PubMed  Google Scholar 

  44. Francis A, Fallowfield L, Rea D. The LORIS trial: addressing overtreatment of ductal carcinoma in situ. Clin Oncol. 2015;27:6–8.

    Article  CAS  Google Scholar 

  45. Puliti D, Duffy SW, Miccinesi G, et al. Overdiagnosis in mammographic screening in breast cancer in Europe: a literature review. J Med Screen. 2012;19(1):42–56.

    Article  PubMed  Google Scholar 

  46. Vassilakos P, Catarino R, Boulvain M, Petignat P. Controversies in the mammography screening programme in swistzerland. Swiss Med Wkly. 2014;144(w13969):1–3.

    Google Scholar 

  47. Lutz J, Pury P, Fioretta G, Raymond L. The impact of coding process on onserved cancer mortality trends in swistzerland. Eur J Cancer Prev. 2004;13(1):77–81.

    Article  PubMed  Google Scholar 

  48. Stomper PC, D'Souza DJ, DiNitto PA, Arredondo MA. Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. AJR Am J Roentgenol. 1996;167(5):1261–5.

    Article  CAS  PubMed  Google Scholar 

  49. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002;225:165–75.

    Article  PubMed  Google Scholar 

  50. Mortality Statistics: Deaths registered in England and Wales (Series DR). Office of National Statistics (The National Archives) 2012.

    Google Scholar 

  51. Courtney A, Gabriel SMD. Breast cancer in the young. Breast Cancer Res. 2010;12:212.

    Article  Google Scholar 

  52. Moser K, Sellars S, Wheaton M, Cooke J, Duncan A, Maxwell A, Michell M, Wilson M, Beral V, Peto R, Richards M, Patnick J. Extending the age range for breast screening in England: pilot study to assess the feasibility and acceptability of randomization. J Med Screen. 2011;18(2):96–102.

    Article  PubMed  Google Scholar 

  53. Moss SM, Wale C, Smith R, et al. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK age trial at 17 years’ follow-up: a randomised controlled trial. Lancet Oncol. 2015;16(9):1123–32.

    Article  PubMed  Google Scholar 

  54. Beemsterboer PM, Warmerdam PG, Boer R, de Koning HJ. Radiation risk of mammography related to benefit in screening programmes: a favourable balance? J Med Screen. 1998;5(2):81–7.

    Article  CAS  PubMed  Google Scholar 

  55. Giorgi D, Giordano L, Ventura L, Frigerio A, Paci E, Zappa M. Mammography breast cancer screening in Italy: 2010 survey. Epidemiol Prev. 2012;36(6):8–27.

    PubMed  Google Scholar 

  56. Domingo L, Jacobsen KK, von Euler-Chelpin M, et al. Seventeen-years overview of breast cancer inside and outside screening in Denmark. Acta Oncol. 2013;52:48–56.

    Article  PubMed  Google Scholar 

  57. Séradour B. Breast cancer screening in France: an overview in 2009. Rev Prat. 2010;60:191–9.

    PubMed  Google Scholar 

  58. Biesheuvel C, Weigel S, Heindel W. Mammography screening: evidence, history and current practice in Germany and other European countries. Breast Care (Basel). 2011;6:104–9. 2011;6:104-09

    Article  Google Scholar 

  59. Quinn M, Allen E. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Registries. BMJ. 1995;311(7017):1391–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. England PH. NHS breast screening programme and Association of Breast Surgery. An audit of screen detected breast cancers for the year of screening April 2014 to March 2015. 2016.

    Google Scholar 

  61. Association of Breast Surgery at B. Surgical guidelines for the management of breast cancer. Eur J Surg Oncol. 2009;35(Suppl 1):1–22. doi: S0748-7983(09)00027-4 [pii] 10.1016/j.ejso.2009.01.008 [doi][published Online First: Epub Date]|.

    Article  Google Scholar 

  62. http://www.cancerscreening.nhs.uk/breastscreen/second-all-breast-cancer-report.pdf af. The Second All Breast Cancer report. London: NCIN 2011 2011.

Download references

Author information

Authors and Affiliations

  1. Royal Derby Hospital, Derby, UK

    John Mathew DM, FRCS & Mark Sibbering FRCS

Authors
  1. John Mathew DM, FRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark Sibbering FRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark Sibbering FRCS .

Editor information

Editors and Affiliations

  1. The Medical School Department of Oncology, University of Sheffield, Sheffield, United Kingdom

    Lynda Wyld

  2. Athens University Medical School, Athens, Greece

    Christos Markopoulos

  3. Helsinki University Hospital, Helsinki, Finland

    Marjut Leidenius

  4. Department of Oncology & Radiotherapy, Gdańsk Medical University Department of Oncology & Radiotherapy, Gdańsk, Poland

    Elżbieta Senkus-Konefka

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Mathew, J., Sibbering, M. (2018). Breast Cancer Screening. In: Wyld, L., Markopoulos, C., Leidenius, M., Senkus-Konefka, E. (eds) Breast Cancer Management for Surgeons. Springer, Cham. https://doi.org/10.1007/978-3-319-56673-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56673-3_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56671-9

  • Online ISBN: 978-3-319-56673-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation